Secondly, since we proposed and confirmed the role of BMAL1 in the contribution of hyperandrogenism to insulin resistance in PCOS, it might be a novel potential therapeutic target for PCOS patients. The gene discussed is BMAL1; the disease is polycystic ovary syndrome.